Role of HLA-B α-3 domain amino acid position 194 in HIV disease progression

Molecular Immunology

Volumn 53, Issue 4, 2013, Pages 410-413

  Grifoni, Alba ^a   Montesano, Carla ^a   Palma, Paolo ^b   Salerno, Alfredo ^c   Colizzi, Vittorio ^a   Amicosante, Massimo ^a,d  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

^d ProxAgen Ltd   (Bulgaria)

Author keywords

Epitope Bw4; HIV progression; HLA B; LIR1

Indexed keywords

AMINO ACID; HLA B ANTIGEN;

ALLELE; AMINO ACID SEQUENCE; ARTICLE; CHILD; DISEASE COURSE; GENETIC POLYMORPHISM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MOLECULAR MODEL; PRIORITY JOURNAL;

AMINO ACID SUBSTITUTION; ANTIGENS, CD; BINDING SITES; CHILD; CROSS INFECTION; DISEASE PROGRESSION; GENE EXPRESSION; HIV INFECTIONS; HIV-1; HLA-B ANTIGENS; HUMANS; IMMUNITY, INNATE; MODELS, MOLECULAR; POLYMORPHISM, GENETIC; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, IMMUNOLOGIC; RECEPTORS, KIR3DL1; RECEPTORS, KIR3DS1; SIGNAL TRANSDUCTION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84867748448     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2012.09.009     Document Type: Article

References (20)

1. Boulet S., Song R., Kamya P., Bruneau J., Shoukry N.H., Tsoukas C.M., Bernard N.F. HIV protective KIR3DL1 and HLA-B genotypes influence NK cell function following stimulation with HLA-devoid cells. Journal of Immunology 2010, 184:2057-2064.
2. Boyington J.C., Sun P.D. A structural perspective on MHC class I recognition by killer cell immunoglobulin-like receptors. Molecular Immunology 2002, 38:1007-1021.
3. Carrington M., Martin M.P., van Bergen J. KIR-HLA intercourse in HIV disease. Trends in Microbiology 2008, 16:620-627.
4. CDC Revised classification system for human immunodeficency virus infection in children less than 13 years of age. Morbidity and Mortality Weekly Report 1994, 43:1-10.
5. Chen Y., Shi Y., Cheng H., An Y.Q., Gao G.F. Structural immunology and crystallography help immunologists see the immune system in action: how T and NK cells touch their ligands. IUBMB Life 2009, 61:579-590.
6. Clements C.S., Kjer-Nielsen L., McCluskey J., Rossjohn J. Structural studies on HLA-G: implications for ligand and receptor binding. Human Immunology 2007, 68:220-226.
7. de Oliveira T., Pybus O.G., Rambaut A., Salemi M., Cassol S., Ciccozzi M., Rezza G., Gattinara G.C., D'Arrigo R., Amicosante M., Perrin L., Colizzi V., Perno C.F. Molecular epidemiology: HIV-1 and HCV sequences from Libyan outbreak. Nature 2006, 444:836-837.
8. Hoglund P., Brodin P. Current perspectives of natural killer cell education by MHC class I molecules. Nature Reviews Immunology 2010, 10:724-734.
9. Huang J., Burke P.S., Cung T.D., Pereyra F., Toth I., Walker B.D., Borges L., Lichterfeld M., Yu X.G. Leukocyte immunoglobulin-like receptors maintain unique antigen-presenting properties of circulating myeloid dendritic cells in HIV-1-infected elite controllers. Journal of Virology 2010, 84:9463-9471.
10. Iannello A., Debbeche O., Samarani S., Ahmad A. Antiviral NK cell responses in HIV infection: I NK cell receptor genes as determinants of HIV resistance and progression to AIDS. Journal of Leukocyte Biology 2008, 84:1-26.
11. Jamil K.M., Khakoo S.I. KIR/HLA interactions and pathogen immunity. Journal of Biomedical and Biotechnology 2011, 2011:298348.
12. Jones D.C., Kosmoliaptsis V., Apps R., Lapaque N., Smith I., Kono A., Chang C., Boyle L.H., Taylor C.J., Trowsdale J., Allen R.L. HLA class I allelic sequence and conformation regulate leukocyte Ig-like receptor binding. Journal of Immunology 2011, 186:2990-2997.
13. Lichterfeld M., Yu X.G. The emerging role of leukocyte immunoglobulin-like receptors (LILRs) in HIV-1 infection. Journal of Leukocyte Biology 2012, 91:27-33.
14. Mavilio D., Benjamin J., Daucher M., Lombardo G., Kottilil S., Planta M.A., Marcenaro E., Bottino C., Moretta L., Moretta A., Fauci A.S. Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:15011-15016.
15. O'Connor G.M., Holmes A., Mulcahy F., Gardiner C.M. Natural Killer cells from long-term non-progressor HIV patients are characterized by altered phenotype and function. Clinical Immunology 2007, 124:277-283.
16. Pereyra F., Jia X., McLaren P.J., Telenti A., de Bakker P.I., Walker B.D., Ripke S., Brumme C.J., Pulit S.L., Carrington M., Kadie C.M., Carlson J.M., Heckerman D., Graham R.R., Plenge R.M., Deeks S.G., Gianniny L., Crawford G., Sullivan J., Gonzalez E., Davies L., Camargo A., Moore J.M., Beattie N., Gupta S., Crenshaw A., Burtt N.P., Guiducci C., Gupta N., Gao X., Qi Y., Yuki Y., Piechocka-Trocha A., Cutrell E., Rosenberg R., Moss K.L., Lemay P., O'Leary J., Schaefer T., Verma P., Toth I., Block B., Baker B., Rothchild A., Lian J., Proudfoot J., Alvino D.M., Vine S., Addo M.M., Allen T.M., Altfeld M., Henn M.R., Le Gall S., Streeck H., Haas D.W., Kuritzkes D.R., Robbins G.K., Shafer R.W., Gulick R.M., Shikuma C.M., Haubrich R., Riddler S., Sax P.E., Daar E.S., Ribaudo H.J., Agan B., Agarwal S., Ahern R.L., Allen B.L., Altidor S., Altschuler E.L., Ambardar S., Anastos K., Anderson B., Anderson V., Andrady U., Antoniskis D., Bangsberg D., Barbaro D., Barrie W., Bartczak J., Barton S., Basden P., Basgoz N., Bazner S., Bellos N.C., Benson A.M., Berger J., Bernard N.F., Bernard A.M., Birch C., Bodner S.J., Bolan R.K., Boudreaux E.T., Bradley M., Braun J.F., Brndjar J.E., Brown S.J., Brown K., Brown S.T., et al. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 2010, 330:1551-1557.
17. Sanjanwala B., Draghi M., Norman P.J., Guethlein L.A., Parham P. Polymorphic sites away from the Bw4 epitope that affect interaction of Bw4+ HLA-B with KIR3DL1. Journal of Immunology 2008, 181:6293-6300.
18. Voorter C.E., Amicosante M., Berretta F., Groeneveld L., Drent M., van den Berg-Loonen E.M. HLA class II amino acid epitopes as susceptibility markers of sarcoidosis. Tissue Antigens 2007, 70:18-27.
19. Voorter C.E., van der Vlies S.A., van den Berg-Loonen E.M. Sequence-based typing of HLA-B: the B7 cross-reacting group. Tissue Antigens 2000, 56:356-362.
20. Willcox B.E., Thomas L.M., Bjorkman P.J. Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor. Nature Immunology 2003, 4:913-919. http://www.ebi.ac.uk/imgt/hla/align.html.